Remimazolam and Emergence Delirium in Pediatrics
Recruiting
Phase 4
Interventional Study
Pediatric
Neurosurgery
Sevoflurane Anesthesia
Remimazolam
Emergence Delirium
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 1 – 6
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 248 (estimated)
- Sponsor
- Peking University First Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Emergence delirium is a common complication in pediatrics undergoing neurosurgery. Previous study showed that a single bolus of remimazolam was associated with lower incidence of postoperative agitation. Present study was designed to investigate if remimazolam supplemented to sevoflurane anesthesia could decrease the risk of emergence delirium in pediatrics undergoing neurosurgery.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged 1 to 6 years old
* Planned to receive elective neurosurgery under general anesthesia
* Expected duration of surgery \> 1 hour
Exclusion Criteria:
* Allergy to benzodiazepine
* Use of other sedatives within 12 hours before surgery such as benzodiazepines, propofol, chlor…
Contacts